Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 42Parkinson Disease 4, Autosomal Dominant Lewy Body 29Carcinoma, Renal Cell 26Endometrial Neoplasms 13Melanoma 10Neoplasms 8Cholangiocarcinoma 8Uterine Cervical Neoplasms 7Biliary Tract Neoplasms 7Liver Neoplasms 6Stomach Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neuroendocrine Tumors 5Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Ovarian Neoplasms 4Neoplasm Metastasis 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Thyroid Carcinoma, Anaplastic 3Recurrence 3Kidney Neoplasms 3Esophageal Neoplasms 3Diabetes Mellitus, Insulin-Dependent, 12 3Cirrhosis, Familial, with Pulmonary Hypertension 3Carcinoma, Adenoid Cystic 3Breast Neoplasms 3Brain Neoplasms 3Adenocarcinoma 3

Interventions

Cyclophosphamide 3regorafenib 2Proton Therapy 2Methods 2Gemcitabine 2Doxorubicin 2tocilizumab 1poly ICLC 1pembrolizumab 1liposomal doxorubicin 1lenvatinib 1fludarabine 1flt3 ligand protein 1endostar protein 1alectinib 1aldesleukin 1Weight-Bearing 1Transcranial Direct Current Stimulation 1Taxes 1Surveys and Questionnaires 1Standard of Care 1Restraint, Physical 1Range of Motion, Articular 1Radiotherapy 1Radiosurgery 1Radiation 1Quality of Life 1Psychology, Positive 1Platinum 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × lenvatinib × 1 year × Clear all
NCT07619950 2026-06-02

EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma

Yonsei University

Phase 2 Not yet recruiting
94 enrolled
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡